Cita APA

Luo, J., Wang, K., Liu, D., Liang, B., & Liu, C. (2016). Can roflumilast, a phosphodiesterase-4 inhibitor, improve clinical outcomes in patients with moderate-to-severe chronic obstructive pulmonary disease? A meta-analysis. Respir Res.

Chicago Style Citation

Luo, Jian, Ke Wang, Dan Liu, Bin-Miao Liang, i Chun-Tao Liu. "Can Roflumilast, a Phosphodiesterase-4 Inhibitor, Improve Clinical Outcomes in Patients With Moderate-to-severe Chronic Obstructive Pulmonary Disease? A Meta-analysis." Respir Res 2016.

Cita MLA

Luo, Jian, et al. "Can Roflumilast, a Phosphodiesterase-4 Inhibitor, Improve Clinical Outcomes in Patients With Moderate-to-severe Chronic Obstructive Pulmonary Disease? A Meta-analysis." Respir Res 2016.